BTLA interacts with HVEM

Stable Identifier
R-HSA-389523
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The B and T lymphocyte attenuator (BTLA) is a co-inhibitory receptor belonging to the CD28 superfamily, alongside CTLA-4 and PD-1. Unlike other members of the CD28 family, BTLA possesses an extracellular Ig C-like domain rather than a V-like domain. Its ligand, the Herpesvirus entry mediator (HVEM), represents the first known example of a functional interaction between a TNF receptor (TNFR) family member and an Ig superfamily member. The binding of HVEM to BTLA delivers an inhibitory signal to T cells, playing a crucial role in regulating immune responses and maintaining immune homeostasis (Murphy et al. 2006).
Literature References
PubMed ID Title Journal Year
15568026 B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator

Sedy, JR, Gavrieli, M, Potter, KG, Hurchla, MA, Lindsley, RC, Hildner, K, Scheu, S, Pfeffer, K, Ware, CF, Murphy, TL, Murphy, KM

Nat. Immunol. 2005
16932752 Balancing co-stimulation and inhibition with BTLA and HVEM

Murphy, KM, Nelson, CA, Sedý, JR

Nat Rev Immunol 2006
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!